B) Profiles of the 24 hours continuous glucose monitoring for each treatment group In terms of secondary outcome measures and adverse events, the results of the study reported that all treatment groups experienced significant reductions in total cholesterol, triglycerides, LDL cholesterol, and VLDL cholesterol
Keremi, B., Lohinai, Z., Komlosi, K., Pinter, E., Gyires, K., Szekely, A
Despite appearing promising, it remains unclear whether the positive effects of triple agonists differ from those seen in dual GLP-1/GIP agonists
In extreme cases, electrolyte imbalances trigger cardiac arrhythmias and seizures, requiring emergency intervention
Reserva tu protocolo GLP-1 con seguimiento nutricional integrado En Sant no dispensamos GLP-1, lo integramos dentro de un protocolo mdico-nutricional
Aging Pathobiology and Therapeutics (2022) 4